Fecal microbiota transplants may help patients with gastrointestinal cancers overcome resistance to immune checkpoint inhibitor therapy, a study suggests.
The following is a summary of “Rational design of live biotherapeutic products for the prevention of Clostridioides difficile infection,” published in the September 2024 issue of Infectious Disease by ...
Although the most common application for FMT has been in the setting of recurrent CDI, there is ongoing research to assess benefit in other gastrointestinal diseases. These include inflammatory ...
Researchers at the University of Jyväskylä explored the opportunities to use the composition of the bacterial community, or microbiota, in horse fecal samples as a non-invasive diagnostic tool ...